What are Fulgent Genetics, Inc.'s profit margins?

Fulgent Genetics, Inc. (FLGT) runs a 38.7% gross margin and a -33.1% operating margin, with a -23.0% net margin.

Where do Fulgent Genetics, Inc.'s ratios come from?

Every ratio is computed from Fulgent Genetics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Fulgent Genetics, Inc. FLGT Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	40.6%+2.7pp	37.8%+1.7pp	36.1%-23.2pp	59.3%-19.0pp
Operating margin	-28.2%-2.2pp	-26.1%+41.5pp	-67.6%-96.5pp	28.8%-39.3pp
Net margin	-18.8%-3.7pp	-15.1%+43.0pp	-58%-81.2pp	23.2%-27.9pp
Returns
Return on equity	-5.4%-1.6pp	-3.8%+10.2pp	-14%-25.8pp	11.8%-46.9pp
Return on invested capital	-8.5%-1.5pp	-6.9%+10.4pp	-17.3%-29.8pp	12.5%-55.0pp
Efficiency
Asset turnover	0.3×0.0×	0.2×0.0×	0.2×-0.2×	0.5×-0.5×
Liquidity
Current ratio	6.5×+1.6×	4.9×-2.1×	7×-0.2×	7.1×+1.3×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$36.13-3.6%	$37.48-1.7%	$38.14-6.8%	$40.91+9.4%
Valuation
Market capitalization	$552.11M-7.1%	$564.94M-34.1%	$856.69M-4.8%	$900.1M-70.0%
Price / sales	1.7×-0.3×	2×-1.0×	3×+1.5×	1.5×-1.6×
Price / book	0.5×0.0×	0.5×-0.3×	0.8×0.0×	0.7×-1.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Fulgent Genetics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Fulgent Genetics, Inc.'s profit margins?: Fulgent Genetics, Inc. (FLGT) runs a 38.7% gross margin and a -33.1% operating margin, with a -23.0% net margin.
Where do Fulgent Genetics, Inc.'s ratios come from?: Every ratio is computed from Fulgent Genetics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.